Evidence map›Paper›PMID 34130712›Full record

ArticleJournal of neuroinflammation2021

Microglia RAGE exacerbates the progression of neurodegeneration within the SOD1

Michael MacLean, Judyta Juranek, Swetha Cuddapah, Raquel López-Díez, Henry H Ruiz, Jiyuan Hu, Laura Frye, Huilin Li, Paul F Gugger, Ann Marie Schmidt

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Current Evidence on the Involvement of RAGE-Diaph1 Signaling in the Pathology and Treatment of Neurodegenerative Diseases-An Overview.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Receptors on Microglia.Advances in neurobiology · 2024
    Review
  14. Review
  15. Article
  16. Article
  17. Role of neuroinflammation in neurodegeneration development.Signal transduction and targeted therapy · 2023
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Michael MacLeanDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Judyta JuranekDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Swetha CuddapahDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Raquel López-DíezDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Henry H RuizDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Jiyuan HuDivision of Biostatistics, Department of Population Health and the Department of Environmental Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Laura FryeDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Huilin LiDivision of Biostatistics, Department of Population Health and the Department of Environmental Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Paul F GuggerDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA.
Ann Marie SchmidtDiabetes Research Program, Department of Medicine, New York University Grossman School of Medicine, New York, NY, 10016, USA. AnnMarie.Schmidt@nyulangone.org.ORCID http://orcid.org/0000-0001-8902-070X

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ANIRBAN MAITRA · 1985 to 2026
$83.1M
RAGE: A Potential Contributor to Neuroinflammation in Amyotrophic Lateral SclerosisF31NS120424 · NINDS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MACLEAN, MICHAEL · 2020 to 2020
$43k
National Institute of Neurological Disorders and Stroke (US) F31NS120424NCI NIH HHS P30 CA016087NINDS NIH HHS F31 NS120424U.S. Department of Defense W81XWH-17-1-0346
6 · The paper itself

Abstract

backgroundBurgeoning evidence highlights seminal roles for microglia in the pathogenesis of neurodegenerative diseases including amyotrophic lateral sclerosis (ALS). The receptor for advanced glycation end products (RAGE) binds ligands relevant to ALS that accumulate in the diseased spinal cord and RAGE has been previously implicated in the progression of ALS pathology.

methodsWe generated a novel mouse model to temporally delete Ager from microglia in the murine SOD1

resultsTranscriptomic analysis of human cervical spinal cord reveals a range of AGER expression in ALS patients, which was negatively correlated with age at disease onset and death or tracheostomy. The degree of AGER expression related to differential expression of pathways involved in extracellular matrix, lipid metabolism, and intercellular communication. Microglia display increased RAGE immunoreactivity in the spinal cords of high AGER expressing patients and in the SOD1

conclusionsOur results indicate that microglia RAGE disrupts communications with cell types including astrocytes and neurons, intercellular communication pathways that divert microglia from a homeostatic to an inflammatory and tissue-injurious program. In totality, microglia RAGE contributes to the progression of SOD1

Indexed as

Sex CharacteristicsAmyotrophic Lateral SclerosisAnimalsAstrocytesDisease Models, AnimalDisease ProgressionFemaleGliosisHumansMaleMiceMice, Inbred C57BLMice, TransgenicMicrogliaMotor NeuronsReceptor for Advanced Glycation End ProductsReceptor for Advanced Glycation End ProductsSuperoxide Dismutase-1ALSAstrocytesMacrophageMicrogliaNeurodegenerationRAGE

Identifiers

PMID34130712
PMCPMC8207569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.